Research and Development

AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …

Clinical trials e-solutions firm CRF Health has announced two new additions to the company’s executive leadership team. John Blakeley (pictured) …

The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …

Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

Sharp Packaging Services that is a part of UDG Healthcare has announced that Mike O’Hara has joined the firm as …

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

Virgo has promoted its long-standing employee Natasha Weeks (pictured) to the position of director and lead of its Consumer Health …

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …